These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3717933)

  • 21. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
    Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
    Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aztreonam. Diffusion into bronchial mucus].
    Morel C; Vergnaud M; Malbruny B; Meulemans A; Monrocq N
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):533-7. PubMed ID: 3911150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.
    McCracken GH; Sakata Y; Olsen KD
    Antimicrob Agents Chemother; 1985 Apr; 27(4):655-6. PubMed ID: 3890733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of aztreonam in pediatric patients: a review.
    Bosso JA; Black PG
    Pharmacotherapy; 1991; 11(1):20-5. PubMed ID: 1902290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
    Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
    Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose pharmacokinetics of aztreonam in pediatric patients.
    Stutman HR; Marks MI; Swabb EA
    Antimicrob Agents Chemother; 1984 Aug; 26(2):196-9. PubMed ID: 6541452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and pharmacokinetic evaluations of aztreonam in children].
    Meguro H; Arimasu O; Sugamata K; Hiruma F; Sohda H; Shiraishi H; Fujii R
    Jpn J Antibiot; 1985 Nov; 38(11):3217-29. PubMed ID: 4094055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefoperazone pharmacokinetics in acute childhood meningitis.
    Chartrand SA; Marks MI; Johnston JT; Frederick DF; Scribner RK
    J Pediatr; 1983 Dec; 103(6):991-5. PubMed ID: 6644441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How and why aztreonam works.
    Rittenbury MS
    Surg Gynecol Obstet; 1990; 171 Suppl():19-23. PubMed ID: 2244291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
    Landesman SH; Corrado ML; Cherubin CC; Gombert M; Cleri D
    Am J Med; 1980 Jul; 69(1):92-8. PubMed ID: 6446240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aztreonam for treating meningitis caused by gram-negative rods.
    Kilpatrick M; Girgis N; Farid Z; Bishay E
    Scand J Infect Dis; 1991; 23(1):125-6. PubMed ID: 2028226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefoxitin penetration into cerebrospinal fluid in patients with purulent meningitis.
    Galvao PA; Lomar AV; Francisco W; de Godoy CV; Norrby R
    Antimicrob Agents Chemother; 1980 Apr; 17(4):526-9. PubMed ID: 7396448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis.
    Foulds G; McBride TJ; Knirsch AK; Rodriguez WJ; Khan WN
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1703-5. PubMed ID: 3435118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience of latamoxef in the field of neurosurgery on the penetration into the cerebrospinal fluid in the patients with postoperative meningitis].
    Miyake S; Tanigawa M; Manabe T; Asano T; Niimi H; Kamata I
    Jpn J Antibiot; 1985 Dec; 38(12):3464-70. PubMed ID: 3834129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of aztreonam after intravenous infusion.
    Scully BE; Swabb EA; Neu HC
    Antimicrob Agents Chemother; 1983 Jul; 24(1):18-22. PubMed ID: 6684898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aztreonam therapy for serious gram-negative infections in children.
    Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
    Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aztreonam in the treatment of gram-negative meningitis in children.
    Isani Z; Rehman N; Adil N; el Messidi M
    Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics and extravascular penetration of aztreonam in patients with abdominal sepsis.
    Winslade NE; Smith IL; Simons GW; Swanson DJ; Vigano A; Wels PB; Schentag JJ
    Rev Infect Dis; 1985; 7 Suppl 4():S716-23. PubMed ID: 3909329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.